Compounds > melatonin

melatonin and pioglitazone

melatonin has been researched along with pioglitazone in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
El-Awady, el-S; El-Orabi, N; Hassan, N; Zaitone, S1
Adamkov, M; Bálentová, S; Bojková, B; Demečková, V; Kajo, K; Kružliak, P; Kubatka, P; Orendáš, P; Péč, M; Výbohová, D; Zulli, A1
Han, YS; Kim, SM; Lee, JH; Lee, SH1

Other Studies

6 other study(ies) available for melatonin and pioglitazone

ArticleYear
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Pentoxifylline and melatonin in combination with pioglitazone ameliorate experimental non-alcoholic fatty liver disease.
    European journal of pharmacology, 2011, Jul-15, Volume: 662, Issue:1-3

    Topics: Alanine Transaminase; Animals; Antioxidants; Aspartate Aminotransferases; Biomarkers; Body Weight; Cholesterol; Disease Models, Animal; Drug Interactions; Fatty Liver; Glutathione; Homeostasis; Insulin Resistance; Lipid Peroxidation; Liver; Male; Melatonin; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Pentoxifylline; Pioglitazone; Rats; Rats, Wistar; Thiazolidinediones; Triglycerides; Tumor Necrosis Factor-alpha

2011
Role of high-fat diet on the effect of pioglitazone and melatonin in a rat model of breast cancer.
    European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), 2016, Volume: 25, Issue:5

    Topics: Animals; Antioxidants; Carcinogens; Diet, High-Fat; Disease Models, Animal; Drug Therapy, Combination; Female; Hypoglycemic Agents; Mammary Neoplasms, Experimental; Melatonin; Methylnitrosourea; Pioglitazone; Rats; Rats, Sprague-Dawley; Thiazolidinediones

2016
Co-Administration of Melatonin Effectively Enhances the Therapeutic Effects of Pioglitazone on Mesenchymal Stem Cells Undergoing Indoxyl Sulfate-Induced Senescence through Modulation of Cellular Prion Protein Expression.
    International journal of molecular sciences, 2018, May-04, Volume: 19, Issue:5

    Topics: Adipose Tissue; Animals; Apoptosis; Cell Proliferation; Cellular Senescence; Gene Expression Regulation, Developmental; Humans; Indican; Melatonin; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Pioglitazone; PPAR gamma; Prion Proteins; Signal Transduction; Thiazolidinediones

2018